RecruitingNCT06830590

Study of Molecular Characterisation of Early Operable Primary Breast Cancer in Pakistani Population


Sponsor

Liaquat University of Medical & Health Sciences

Enrollment

300 participants

Start Date

Feb 1, 2016

Study Type

OBSERVATIONAL

Conditions

Summary

This study is looking at the biological characteristics of early operable primary breast cancer in Pakistani Population by using IHC


Eligibility

Sex: FEMALE

Plain Language Summary

Simplified for easier understanding

This study is examining the biological characteristics of early-stage breast cancer in Pakistani women. Researchers will analyze tumor samples to understand how breast cancer behaves differently in this population, which could improve how it is diagnosed and treated locally. **You may be eligible if...** - You are a woman with a confirmed breast cancer diagnosis - Your cancer has not been treated with chemotherapy or other systemic therapy before surgery - A good quality tumor tissue sample is available for laboratory analysis **You may NOT be eligible if...** - You have already received chemotherapy or radiation therapy before surgery (called neoadjuvant treatment) Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREMolecular characterisation

All patients treated by surgery were included without any neoadjuvant therapy


Locations(1)

Binafsha M Syed

Jamshoro, Pakistan

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06830590


Related Trials